Cargando…

RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis

We investigated the functional consequences following deletion of a microRNA (miR) termed miR-595 which resides on chromosome 7q and is localised within one of the commonly deleted regions identified for Myelodysplasia (MDS) with monosomy 7 (−7)/isolated loss of 7q (7q-). We identified several targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhatabi, Heba A., McLornan, Donal P., Kulasekararaj, Austin G., Malik, Farooq, Seidl, Thomas, Darling, David, Gaken, Joop, Mufti, Ghulam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216985/
https://www.ncbi.nlm.nih.gov/pubmed/27374104
http://dx.doi.org/10.18632/oncotarget.10293
_version_ 1782492019597246464
author Alkhatabi, Heba A.
McLornan, Donal P.
Kulasekararaj, Austin G.
Malik, Farooq
Seidl, Thomas
Darling, David
Gaken, Joop
Mufti, Ghulam J.
author_facet Alkhatabi, Heba A.
McLornan, Donal P.
Kulasekararaj, Austin G.
Malik, Farooq
Seidl, Thomas
Darling, David
Gaken, Joop
Mufti, Ghulam J.
author_sort Alkhatabi, Heba A.
collection PubMed
description We investigated the functional consequences following deletion of a microRNA (miR) termed miR-595 which resides on chromosome 7q and is localised within one of the commonly deleted regions identified for Myelodysplasia (MDS) with monosomy 7 (−7)/isolated loss of 7q (7q-). We identified several targets for miR-595, including a large ribosomal subunit protein RPL27A. RPL27A downregulation induced p53 activation, apoptosis and inhibited proliferation. Moreover, p53-independent effects were additionally identified secondary to a reduction in the ribosome subunit 60s. We confirmed that RPL27A plays a pivotal role in the maintenance of nucleolar integrity and ribosomal synthesis/maturation. Of note, RPL27A overexpression, despite showing no significant effects on p53 mRNA levels, did in fact enhance cellular proliferation. In normal CD34+ cells, RPL27A knockdown preferentially blocked erythroid proliferation and differentiation. Lastly, we show that miR-595 expression appears significantly downregulated in the majority of primary samples derived from MDS patients with (−7)/(7q-), in association with RPL27A upregulation. This significant downregulation of miR-595 is also apparent when higher risk MDS cases are compared to lower risk cases. The potential clinical importance of these findings requires further validation.
format Online
Article
Text
id pubmed-5216985
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-52169852017-01-17 RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis Alkhatabi, Heba A. McLornan, Donal P. Kulasekararaj, Austin G. Malik, Farooq Seidl, Thomas Darling, David Gaken, Joop Mufti, Ghulam J. Oncotarget Research Paper We investigated the functional consequences following deletion of a microRNA (miR) termed miR-595 which resides on chromosome 7q and is localised within one of the commonly deleted regions identified for Myelodysplasia (MDS) with monosomy 7 (−7)/isolated loss of 7q (7q-). We identified several targets for miR-595, including a large ribosomal subunit protein RPL27A. RPL27A downregulation induced p53 activation, apoptosis and inhibited proliferation. Moreover, p53-independent effects were additionally identified secondary to a reduction in the ribosome subunit 60s. We confirmed that RPL27A plays a pivotal role in the maintenance of nucleolar integrity and ribosomal synthesis/maturation. Of note, RPL27A overexpression, despite showing no significant effects on p53 mRNA levels, did in fact enhance cellular proliferation. In normal CD34+ cells, RPL27A knockdown preferentially blocked erythroid proliferation and differentiation. Lastly, we show that miR-595 expression appears significantly downregulated in the majority of primary samples derived from MDS patients with (−7)/(7q-), in association with RPL27A upregulation. This significant downregulation of miR-595 is also apparent when higher risk MDS cases are compared to lower risk cases. The potential clinical importance of these findings requires further validation. Impact Journals LLC 2016-06-25 /pmc/articles/PMC5216985/ /pubmed/27374104 http://dx.doi.org/10.18632/oncotarget.10293 Text en Copyright: © 2016 Alkhatabi et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Alkhatabi, Heba A.
McLornan, Donal P.
Kulasekararaj, Austin G.
Malik, Farooq
Seidl, Thomas
Darling, David
Gaken, Joop
Mufti, Ghulam J.
RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis
title RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis
title_full RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis
title_fullStr RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis
title_full_unstemmed RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis
title_short RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis
title_sort rpl27a is a target of mir-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216985/
https://www.ncbi.nlm.nih.gov/pubmed/27374104
http://dx.doi.org/10.18632/oncotarget.10293
work_keys_str_mv AT alkhatabihebaa rpl27aisatargetofmir595andmaycontributetothemyelodysplasticphenotypethroughribosomaldysgenesis
AT mclornandonalp rpl27aisatargetofmir595andmaycontributetothemyelodysplasticphenotypethroughribosomaldysgenesis
AT kulasekararajausting rpl27aisatargetofmir595andmaycontributetothemyelodysplasticphenotypethroughribosomaldysgenesis
AT malikfarooq rpl27aisatargetofmir595andmaycontributetothemyelodysplasticphenotypethroughribosomaldysgenesis
AT seidlthomas rpl27aisatargetofmir595andmaycontributetothemyelodysplasticphenotypethroughribosomaldysgenesis
AT darlingdavid rpl27aisatargetofmir595andmaycontributetothemyelodysplasticphenotypethroughribosomaldysgenesis
AT gakenjoop rpl27aisatargetofmir595andmaycontributetothemyelodysplasticphenotypethroughribosomaldysgenesis
AT muftighulamj rpl27aisatargetofmir595andmaycontributetothemyelodysplasticphenotypethroughribosomaldysgenesis